CS Professional · Goods and Services Tax (GST) and Corporate Tax Planning · Corporate Tax Planning
Demerged company Arjun Ltd has an accumulated business loss of Rs 60 lakh that is not directly relatable to the undertaking transferred to the resulting company. Assets of Rs 30 crore are retained by Arjun Ltd and assets of Rs 20 crore are transferred to the resulting company. How much loss can the resulting company carry forward under section 116 of the Income-tax Act, 2025?
The resulting company gets Rs 24 lakh. A loss not directly relatable to the transferred undertaking is apportioned in the ratio of assets retained to assets transferred, so the resulting company's share is 20/50 of Rs 60 lakh, which equals Rs 24 lakh, and Arjun Ltd keeps Rs 36 lakh.
- ARs 24 lakhCorrect
- BRs 36 lakh
- CRs 30 lakh
- DNil
Explanation
Under section 116(6)(b), a loss not directly relatable is apportioned in the proportion of assets retained to assets transferred. Total assets are 30 + 20 = 50 crore. The resulting company's share is 20/50 x 60 = Rs 24 lakh. Rs 36 lakh is the demerged company's share, from reversing the ratio.
Did you get it right without looking?
One question tells you little. A timed set on Corporate Tax Planning shows your real accuracy, how long you take and where you lose marks.
More Corporate Tax Planning questions
- Ferndale Ltd., a foreign company whose place of effective management is wholly outside India, had these items in the tax year: (i) ₹30 lakh …
- Which statement about the claim of deduction under section 133 for a donation to an institution or fund under section 133(1)(b)(ii) is corre…
- Section 159 of the Income-tax Act, 2025 permits an agreement with another country for avoiding double taxation. What condition does the sect…
- Orbit Securities Pvt Ltd, a broker-dealer, paid ₹3,00,000 as securities transaction tax on taxable securities transactions entered into in t…
- Under section 133 of the Income-tax Act, 2025, a company donates Rs. 5,00,000 by cheque to the Prime Minister's National Relief Fund. What d…
- Meridian Pharma Ltd paid Rs. 8,00,000 in cash to a fund eligible under section 133(1)(a) as a whole-deduction donee. Under the Income-tax Ac…